'

Knowledge center

The place to find all the most innovative research and information on novel biologics and biosimilars.

Press Releases

Bioeq, the Polpharma Biologics Group joint venture company and MS Pharma sign exclusive agreement for Ranibizumab in MENA

Zug, Switzerland – MS Pharma has signed an exclusive licensing and supply agreement with Bioeq AG, Switzerland, the Polpharma Biologics Group joint venture company to commercialize the biosimilar candidate FYB201 (Ranibizumab) in the entire Middle East and North Africa region.

Downloads

You can find all the latest presentations, brochures and fact sheets below covering our solutions and portfolio.

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.